287 related articles for article (PubMed ID: 32047771)
21. Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or proteins?
Loktionov A
World J Gastrointest Oncol; 2020 Feb; 12(2):124-148. PubMed ID: 32104546
[TBL] [Abstract][Full Text] [Related]
22. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
25. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.
Tóth K; Barták BK; Tulassay Z; Molnár B
Expert Rev Mol Diagn; 2016; 16(2):239-52. PubMed ID: 26652067
[TBL] [Abstract][Full Text] [Related]
26. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
27. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas.
Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L
Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510
[TBL] [Abstract][Full Text] [Related]
28. Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality.
D'Andrea E; Ahnen DJ; Sussman DA; Najafzadeh M
Cancer Med; 2020 Jan; 9(2):824-836. PubMed ID: 31777197
[TBL] [Abstract][Full Text] [Related]
29. Detection and clinical significance of circulating tumor cells in colorectal cancer.
Jiang M; Jin S; Han J; Li T; Shi J; Zhong Q; Li W; Tang W; Huang Q; Zong H
Biomark Res; 2021 Nov; 9(1):85. PubMed ID: 34798902
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
[TBL] [Abstract][Full Text] [Related]
31. Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review.
Zhao Z; Zhu A; Bhardwaj M; Schrotz-King P; Brenner H
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008229
[TBL] [Abstract][Full Text] [Related]
32. Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients.
Winter JM; Sheehan-Hennessy L; Yao B; Pedersen SK; Wassie MM; Eaton M; Chong M; Young GP; Symonds EL
Cancer Biomark; 2022; 34(3):493-503. PubMed ID: 35253733
[TBL] [Abstract][Full Text] [Related]
33. Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review.
Song D; Wang F; Ju Y; He Q; Sun T; Deng W; Ding R; Zhang C; Xu Q; Qi C; Bao J
Int J Surg; 2023 Apr; 109(4):925-935. PubMed ID: 36974713
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer screening: the time to act is now.
Brenner H; Stock C; Hoffmeister M
BMC Med; 2015 Oct; 13():262. PubMed ID: 26459270
[TBL] [Abstract][Full Text] [Related]
35. The role of
Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
[TBL] [Abstract][Full Text] [Related]
36. Tests and investigations for colorectal cancer screening.
Carroll MR; Seaman HE; Halloran SP
Clin Biochem; 2014 Jul; 47(10-11):921-39. PubMed ID: 24769265
[TBL] [Abstract][Full Text] [Related]
37. Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests.
Song LL; Li YM
World J Gastrointest Oncol; 2016 Nov; 8(11):793-800. PubMed ID: 27895817
[TBL] [Abstract][Full Text] [Related]
38. Comparative effectiveness of screening strategies for colorectal cancer.
Barzi A; Lenz HJ; Quinn DI; Sadeghi S
Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
[TBL] [Abstract][Full Text] [Related]
39. Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge.
Junca A; Tachon G; Evrard C; Villalva C; Frouin E; Karayan-Tapon L; Tougeron D
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517177
[TBL] [Abstract][Full Text] [Related]
40. Using Comorbidity Pattern Analysis to Detect Reliable Methylated Genes in Colorectal Cancer Verified by Stool DNA Test.
Cheng YC; Wu PH; Chen YJ; Yang CH; Huang JL; Chou YC; Chang PK; Wen CC; Jao SW; Huang HH; Tsai YH; Pai TW
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
